683 Capital Management »

Protara Therapeutic shares owned by 683 Capital Management

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $330k 62k 5.28

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Protara Therapeutic

Henderson Group
BlackRock
Velan Capital Investment Management
Blackstone Group
Vanguard Group
Acorn Capital Advisors
Catalio Capital Management
Integral Health Asset Management
UBS Group
5AM Venture Management
Geode Capital Management
Millennium Management
Baker Bros. Advisors
Citadel Advisors
Driehaus Capital Management

View all funds holding Protara Therapeutic